top of page
Restoring Your Sense of Smell
Sensory Restoration Technologies
(SRT) is leading the way with real
solutions for patients living with the
loss of smell, medically known as
anosmia. Currently in development,
our revolutionary olfactory implant
system is designed to detect smell
particles and stimulate brain activity, emulating a sense of smell.

Anosmia: A Hidden Problem
Patients with anosmia experience the loss of smell. This can be triggered by traumatic brain injury, illness, or underlying conditions that impact the part of the brain responsible for receiving this sensation.
The sense of smell acts as an early warning system. On top of blocking pleasant smells, anosmia can be dangerous because it diminishes the ability to detect potential threats like smoke, gas leaks, or spoiled food.
Living with Anosmia
Our Technology
Our system bridges the sense of smell to the brain. Similar to how cochlear implants restore hearing loss, we use technology to stimulate signals in the brain’s olfactory cortex to perceive a sense of smell.
How It Works
This illustration models how the smell restoration device would function. The device includes sensors to detect odor particles and processors that sends electrical currents to directly stimulate the brain’s olfactory centers and create a sensation of smell.

-
The external sensors detect odors.
-
Signals from the sensor transmit to the external processor to be coded.
-
The external processor sends a unique code (based on the odorants) to the transmitter.
-
The transmitter sends the signal wirelessly acorss the scalp to the internal receiver-stimulator.
-
The internal receiver-stimulator sends the signal through a wire to the electrode array on the olfactory bulb.
-
The olfactory bulb is stimulated with a unique pattern based on the original odor.
-
Brain perceives a sense of smell.
What's next?
SRT continues to lead the world in development of restorative technologies for the senses. Our current work is focusing on the Olfactory Implant System (OIS), which is in the pre-clinical phase. First-in-human prototype testing is our next step.
Interested in receiving updates on our progress?
bottom of page



